KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.
KensaGroup co-founder Tony Eisenhut discusses successful characteristics of entrepreneurs.
KensaGroup co-founder Bruce Ganem discusses the diferent challenges scientists face in product invention versus execution of a company.
05.01.13 - GNS Healthcare licenses its Reverse Engineering and Forward Simulation (REFS™) big data analytics platform to Harvard Medical School...more
04.24.13 - Novasterilis reaches 24,000 sterilizations of allograft tissue, including tendons and bones, using their patented supercritical CO2 sterilization process...more
04.18.13 - GNS Healthcare announces partnership with the Centers for Medicare and Medicaid Services (CMS) and the Health Services Advisory Group (HSAG) to assess the impact of health reform quality measures using big data analytics...more
04.15.13 - Colin Hill, CEO of GNS Healthcare, is featured in an article on the progressive emergence of data-driven decision making for healthcare...more
03.27.13 - Novomer awarded $5 million from the Department of Energy to develop technologies for the repurposing of waste CO2 from industrial sources...more
02.20.13 - Novomer completes the world's first large-scale manufacturing run of polypropylene carbonate (PPC) polyol, producing over seven tons of finished product...more
KensaGroup, LLC
950 Danby Road
Suite 300
Ithaca, NY 14850
phone: 1.607.330.2307
Fax: 1.607.330.2319